Eija Nissila

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab.

The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab.

Journal: Microbiology spectrum

Published: July 07, 2025

Loss of CFHR5 function reduces the risk for age-related macular degeneration.

Loss of CFHR5 function reduces the risk for age-related macular degeneration.

Journal: medRxiv : the preprint server for health sciences

Published: November 28, 2024

Loss of CFHR5 function reduces the risk for age-related macular degeneration.

Loss of CFHR5 function reduces the risk for age-related macular degeneration.

Journal: Nature communications

Published: November 11, 2024

The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosis.

The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosis.

Journal: Scandinavian journal of immunology

Published: June 11, 2024

Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation.

Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation.

Journal: EMBO reports

Published: November 11, 2022

Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease.

Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease.

Journal: Inflammatory bowel diseases

Published: March 28, 2022

Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease.

Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis

Published: December 10, 2020

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles.

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles.

Journal: iScience

Published: October 29, 2020

Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages.

Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages.

Journal: Frontiers in immunology

Published: August 21, 2018

C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease.

C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease.

Journal: Clinical and experimental immunology

Published: August 08, 2017

Correction: Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.

Correction: Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.

Journal: PloS one

Published: July 13, 2017

Upregulation of Early and Downregulation of Terminal Pathway Complement Genes in Subcutaneous Adipose Tissue and Adipocytes in Acquired Obesity.

Upregulation of Early and Downregulation of Terminal Pathway Complement Genes in Subcutaneous Adipose Tissue and Adipocytes in Acquired Obesity.

Journal: Frontiers in immunology

Published: February 07, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026